Improvement of dysphagia in a child affected by Pompe disease treated with enzyme replacement therapy

被引:0
|
作者
Simona Fecarotta
Serena Ascione
Giuseppe Montefusco
Roberto Della Casa
Paola Villari
Alfonso Romano
Ennio Del Giudice
Generoso Andria
Giancarlo Parenti
机构
[1] Sezione di Pediatria,Dipartimento di Scienze Mediche Traslazionali
[2] Università di Napoli Federico II,Dipartimento di Otorinolaringoiatria e Scienze Affini
[3] Università di Napoli Federico II,undefined
来源
Italian Journal of Pediatrics | / 39卷
关键词
Glycogen storage disease type II; Deglutition disorders; Enzyme replacement therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease
    An, Y
    Young, SP
    Kishnani, PS
    Millington, DS
    Amalfitano, A
    Corzo, D
    Chen, YT
    MOLECULAR GENETICS AND METABOLISM, 2005, 85 (04) : 247 - 254
  • [22] Pompe disease in adulthood: effects of antibody formation on enzyme replacement therapy
    de Vries, Juna M.
    Kuperus, Esther
    Hoogeveen-Westerveld, Marianne
    Kroos, Marian A.
    Wens, Stephan C. A.
    Stok, Merel
    van der Beek, Nadine A. M. E.
    Kruijshaar, Michelle E.
    Rizopoulos, Dimitris
    van Doorn, Pieter A.
    van der Ploeg, Ans T.
    Pijnappel, W. W. M. Pim
    GENETICS IN MEDICINE, 2017, 19 (01) : 90 - 97
  • [23] Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
    Tarallo, Antonietta
    Damiano, Carla
    Strollo, Sandra
    Minopoli, Nadia
    Indrieri, Alessia
    Polishchuk, Elena
    Zappa, Francesca
    Nusco, Edoardo
    Fecarotta, Simona
    Porto, Caterina
    Coletta, Marcella
    Iacono, Roberta
    Moracci, Marco
    Polishchuk, Roman
    Medina, Diego Luis
    Imbimbo, Paola
    Monti, Daria Maria
    De Matteis, Maria Antonietta
    Parenti, Giancarlo
    EMBO MOLECULAR MEDICINE, 2021, 13 (11)
  • [24] Improved Exercise Tolerance after Enzyme Replacement Therapy in Pompe Disease
    Marzorati, Mauro
    Porcelli, Simone
    Reggiori, Barbara
    Morandi, Lucia
    Grassi, Bruno
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 (05) : 771 - 775
  • [25] β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease
    Koeberl, Dwight D.
    Li, Songtao
    Dai, Jian
    Thurberg, Beth L.
    Bali, Deeksha
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : 221 - 227
  • [27] Teaching tolerance New approaches to enzyme replacement therapy for Pompe disease
    Cousens, Leslie P.
    Mingozzi, Federico
    van der Marel, Sander
    Su, Yan
    Garman, Richard
    Ferreira, Valerie
    Martin, William
    Scott, David W.
    De Groot, Anne S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (10) : 1459 - 1464
  • [28] Treatment with enzyme replacement therapy during pregnancy in a patient with Pompe disease
    Holbeck-Brendel, Merete
    Poulsen, Birgitte Klindt
    NEUROMUSCULAR DISORDERS, 2017, 27 (10) : 956 - 958
  • [29] Prolonged survival and improvement of heart and skeletal muscle function under enzyme replacement therapy in infantile Pompe disease
    Dittmar, E
    Görlinger, K
    Neudorf, U
    Bosbach, T
    Straub, V
    Voit, T
    NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 665 - 665
  • [30] Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
    Hundsberger, Thomas
    Rohrbach, Marianne
    Kern, Lukas
    Roesler, Kai M.
    JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2279 - 2285